MiniMed Group, Inc. Common Stock (MMED) is a publicly traded the market company. As of November 13, 2026, MMED trades at $17.75 with a market cap of $5.13B and a P/E ratio of -15.08. MMED moved -0.71% today. Year to date, MMED is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $10.65 to $24.43. Analyst consensus is strong buy with an average price target of $26.15. Rallies surfaces MMED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Medtronic completes separation of MiniMed Group: Medtronic completed its separation of MiniMed Group on October 15, 2026, exchanging its remaining 252,813,348 MiniMed common shares for its own outstanding ordinary shares. The exchange offer was subscribed 5.4 times.
| Metric | Value |
|---|---|
| Price | $17.75 |
| Market Cap | $5.13B |
| P/E Ratio | -15.08 |
| EPS | $-1.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.43 |
| 52-Week Low | $10.65 |
| Volume | 10.03K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.10B |
| Net Income | $-317.00M |
| Gross Margin | 54.16% |
14 analysts cover MMED: 0 strong buy, 12 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $26.15.